Ontology highlight
ABSTRACT: Background
Patients with multiple sclerosis (pwMS) are often treated with disease modifying therapies (DMT) with immunomodulatory effects. This is of particular concern following the development of several vaccines to combat coronavirus disease 19 (COVD-19), a potentially fatal illness caused by SARS-CoV-2.Objectives
To determine the efficacy of SARS-CoV-2 vaccination in pwMS and the impact of disease modifying therapies (DMT) on vaccine response.Methods
This is a prospective longitudinal study in pwMS. Longitudinal serum samples were obtained prior to, and after SARS-CoV-2 mRNA vaccination. A novel neutralizing antibody (nAb) assay was used to determine nAbs titres against SARS-CoV-2 spike.Results
We observed that (1) pwMS on B-cell depleting therapies exhi
SUBMITTER: Gyang TV
PROVIDER: S-EPMC8941285 | biostudies-literature | 2022 Jan-Mar
REPOSITORIES: biostudies-literature